The impact of age on long-term survival following gastrectomy for gastric cancer.


Journal

Annals of the Royal College of Surgeons of England
ISSN: 1478-7083
Titre abrégé: Ann R Coll Surg Engl
Pays: England
ID NLM: 7506860

Informations de publication

Date de publication:
Mar 2023
Historique:
pmc-release: 01 03 2024
pubmed: 22 4 2022
medline: 3 3 2023
entrez: 21 4 2022
Statut: ppublish

Résumé

Gastrectomy remains the primary curative treatment modality for patients with gastric cancer. Concerns exist about offering surgery with a high associated morbidity and mortality to elderly patients. The study aimed to evaluate the long-term survival of patients with gastric cancer who underwent gastrectomy comparing patients aged <70 years with patients aged ≥70 years. Consecutive patients who underwent gastrectomy for adenocarcinoma with curative intent between January 2000 and December 2017 at a single centre were included. Patients were stratified by age with a cut-off of 70 years used to create two cohorts. Log rank test was used to compare overall survival and Cox multivariable regression used to identify predictors of long-term survival. During the study period, 959 patients underwent gastrectomy, 520 of whom (54%) were aged ≥70 years. Those aged <70 years had significantly lower American Society of Anesthesiologists grades ( Low postoperative mortality and good long-term survival were demonstrated for both age groups following gastrectomy. Age ≥70 years was, however, associated with poorer outcomes. This should be regarded as important factor when counselling patients regarding treatment options.

Identifiants

pubmed: 35446718
doi: 10.1308/rcsann.2021.0355
pmc: PMC9974338
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

269-277

Références

Gastric Cancer. 2019 Jan;22(1):172-189
pubmed: 29846827
Gastric Cancer. 2007;10(1):39-44
pubmed: 17334717
Ann Surg Oncol. 2017 Aug;24(8):2213-2223
pubmed: 28247154
World J Surg. 2012 Feb;36(2):338-45
pubmed: 22205105
World J Surg. 2016 Jan;40(1):148-57
pubmed: 26350821
Br J Surg. 2018 Aug;105(9):1163-1170
pubmed: 29683186
Eur J Surg Oncol. 2017 Jul;43(7):1330-1336
pubmed: 28359594
Ann Surg Oncol. 2014 Sep;21(9):3008-14
pubmed: 24700300
World J Gastrointest Oncol. 2017 Jun 15;9(6):257-262
pubmed: 28656076
BMJ Open. 2018 Dec 22;8(12):e023190
pubmed: 30580268
J Surg Oncol. 2015 Dec;112(8):883-7
pubmed: 26482869
Eur J Surg Oncol. 2010 Aug;36(8):709-17
pubmed: 20542657
Gastric Cancer. 2019 Jan;22(1):10-22
pubmed: 30276574
World J Surg. 2006 Aug;30(8):1468-74
pubmed: 16850149
Br J Surg. 2011 Feb;98(2):255-60
pubmed: 21082693
Dig Surg. 2020 Dec 8;:1-7
pubmed: 33291099
J Gastrointest Surg. 2016 Sep;20(9):1554-64
pubmed: 27364726
Eur J Surg Oncol. 2018 May;44(5):594-599
pubmed: 29459017
World J Gastroenterol. 2013 Oct 21;19(39):6568-78
pubmed: 24151383
J Cancer. 2018 Mar 8;9(7):1188-1199
pubmed: 29675100
Ann Surg. 2021 Apr 1;273(4):709-718
pubmed: 31188201
Ann Surg Oncol. 2021 Nov;28(12):7291-7297
pubmed: 34041625
Lancet. 1996 Apr 13;347(9007):995-9
pubmed: 8606613
Pilot Feasibility Stud. 2020 Apr 23;6:50
pubmed: 32346484
Eur J Gastroenterol Hepatol. 2004 Jul;16(7):681-8
pubmed: 15201582
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
N Engl J Med. 2006 Jul 6;355(1):11-20
pubmed: 16822992
CA Cancer J Clin. 2017 Mar;67(2):93-99
pubmed: 28094848
Ann Surg Oncol. 2013 Feb;20(2):371-80
pubmed: 22987098
Ann Surg Oncol. 2022 May;29(5):2812-2825
pubmed: 34890023
J Gastric Cancer. 2014 Sep;14(3):173-9
pubmed: 25328762
World J Surg. 2013 Dec;37(12):2891-8
pubmed: 24081528
Surgery. 2021 Jul;170(1):2-10
pubmed: 33674126
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Gastrointest Surg. 2014 Jul;18(7):1269-77
pubmed: 24820136
BMJ Open. 2016 Dec 7;6(12):e012876
pubmed: 27927660
Cancer. 1994 Jun 1;73(11):2680-6
pubmed: 8194005
JAMA Surg. 2021 Oct 1;156(10):954-963
pubmed: 34468701
Lancet. 2019 May 11;393(10184):1948-1957
pubmed: 30982686

Auteurs

L R Brown (LR)

The Newcastle upon Tyne Hospitals NHS Foundation Trust, UK.

S K Kamarajah (SK)

The Newcastle upon Tyne Hospitals NHS Foundation Trust, UK.

A Madhavan (A)

The Newcastle upon Tyne Hospitals NHS Foundation Trust, UK.

S Wahed (S)

The Newcastle upon Tyne Hospitals NHS Foundation Trust, UK.

M Navidi (M)

The Newcastle upon Tyne Hospitals NHS Foundation Trust, UK.

A Immanuel (A)

The Newcastle upon Tyne Hospitals NHS Foundation Trust, UK.

N Hayes (N)

The Newcastle upon Tyne Hospitals NHS Foundation Trust, UK.

A W Phillips (AW)

The Newcastle upon Tyne Hospitals NHS Foundation Trust, UK.
Newcastle University, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH